Moelis & Co
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +16.2% | +11.0% | +16.7% | +30.8% | +17.2% | +11.6% | +30.0% | -21.8% | -3.0% | +16.9% | +31.5% | |
| – | +27.1% | +21.5% | -21.3% | +19.9% | -32.1% | +35.7% | +94.0% | -55.3% | -4.9% | +94.1% | +27.4% | |
| – | +25.3% | +28.6% | -33.2% | +22.5% | -35.7% | +20.7% | +156.9% | -60.2% | -9.9% | +121.3% | +23.3% | |
| – | +25.3% | +28.6% | -33.2% | +22.5% | -35.7% | +20.7% | +156.9% | -60.2% | -9.9% | +121.3% | +23.3% | |
| – | +40.8% | -22.5% | +102.3% | +11.4% | -18.7% | +81.4% | -31.3% | -19.0% | +13.0% | +15.8% | +50.5% | |
| – | – | – | – | – | – | +35.6% | +93.7% | – | – | – | – | |
| – | +18.5% | -3.5% | +24.5% | +21.7% | +9.9% | +257.2% | +18.4% | +254.1% | +12.6% | +4.2% | +24.7% | |
| – | – | – | +39.5% | +72.2% | -0.6% | +6.0% | +5.6% | -4.1% | -96.3% | – | – | |
| – | – | – | – | – | – | – | +4.1% | -42.9% | -29.8% | -17.1% | -19.5% | |
| – | -2.7% | +23.2% | +2.1% | +52.9% | +24.9% | +10.9% | +43.3% | -29.7% | +7.8% | +10.1% | +25.9% | |
| – | -2.8% | +23.9% | +2.3% | +55.1% | -10.4% | +15.6% | +59.4% | -36.2% | +6.4% | +12.4% | -95.7% | |
| – | – | – | – | – | – | +18.1% | +21.2% | -29.5% | +29.2% | +21.1% | +13.7% | |
| – | +6.6% | -32.4% | +27.9% | +45.0% | -39.4% | +55.4% | +179.2% | -82.9% | +173.5% | +3.0% | +29.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +48.5% | +25.8% | +53.4% | +24.4% | +9.5% | +8.4% | +1.9% | -9.1% | -20.8% | +25.4% | +28.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +34.3% | +13.5% | +55.4% | +34.5% | +9.5% | +9.4% | +12.7% | +2.8% | -2.6% | +11.8% | +3.4% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.